Breathe Well Live Well
|
Lotus Pharmaceuticals, Inc. (LTUS) Receives Phase I Approval for Asthma Drug
International Business Times Lotus Pharmaceuticals, Inc. said that research conducted by a third party indicated that the Asthma market in China is approximately $300 million annually, … Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical … |
View full post on asthma – Google News
|
Clinical Data, Inc. Presents Data from Phase I Studies of Stedivaze(TM …
MarketWatch (press release) Currently available adenosine agonists must be used with caution or are contraindicated in patients with asthma and COPD. The findings, presented at the … Clinical Data Reveals Positive Results From Early-stage Trials Of Stedivaze … |
View full post on asthma – Google News
|
Nanotech Industries International Inc. Enters Into Definitive Agreement With …
MarketWatch (press release) In smaller amounts, isocyanates can also sensitize workers, making them subject to severe asthma attacks if they are exposed again. Death from severe asthma … |
View full post on asthma – Google News
|
BreathSlim, Inc. Launches Next-Generation System for Advancement in Weight Loss
PR Newswire (press release) While weight loss goals may be different based on individual needs, the strong correlation between individuals with breathing problems, risk of asthma, … |
View full post on asthma – Google News